Chip Diagnostics

📍 Philadelphia, United States🗓 Founded 2016👥 3 employees💰 Last funded 2016
Biotechnology Research🌐 chip-diagnostics.com
Website LinkedIn
Chip Diagnostics is commercializing an innovative hardware and data/AI informatics platform, used to develop novel, exosome-based biomarker signatures for early disease diagnostics and therapy management. We developed a proprietary workflow to rapidly scan blood samples for trillions of exosomes individually to identify and interpret organ-specific exosome populations. Our solutions enable extremely accurate “fingerprinting” of a broad range of diseases and their states, offering inexpensive, and less time and resource-intensive workflows across biopharma/drug discovery and diagnostics use cases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Chip Diagnostics?
Chip Diagnostics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Chip Diagnostics last raise funding?
The most recent investment in Chip Diagnostics recorded on gritt.io was in 2016.
When was Chip Diagnostics founded?
Chip Diagnostics was founded in 2016.
What industry is Chip Diagnostics in?
Chip Diagnostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Chip Diagnostics based?
Chip Diagnostics is headquartered in Philadelphia, United States.